Clinical trial leadership still includes disproportionately low number of women
Discovering a potential explanation for treatment resistance in skin cancer
28 February 2022Cholesterol-lowering drugs may slow down metastases
28 February 2022Clinical trial leadership still includes disproportionately low number of women
Women remain underrepresented in leading cardiovascular clinical trials, which corresponds with underrepresentation and a lack of gender diversity among presenters at scientific meetings, according to a review published today in the Journal of the American College of Cardiology.
